Sintx Technologies (NASDAQ:SINT) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Sintx Technologies (NASDAQ:SINT) issued its earnings results on Thursday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.07, FiscalAI reports. Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The business had revenue of $2.19 million for the quarter, compared to the consensus estimate of $1.33 million.

Here are the key takeaways from Sintx Technologies’ conference call:

• Third-quarter revenue rose 953% year over year to $2.2 million, primarily on aerospace and industrial manufacturing sales, while gross profit reached $1.4 million and gross margin improved to 62%. Revenue was twice the high end of the company’s prior guidance, which it attributed to customer demand and improved manufacturing execution.
• Net loss narrowed 55% to $1.6 million, and operating expenses fell 13% year over year. Management said the lower reported R&D expense largely reflected overhead reallocation rather than a reduction in underlying research activity.
• Liquidity remains a concern: cash was $2 million at quarter-end, and operating cash use totaled $6.6 million in the first nine months. A post-quarter warrant exercise brought in about $2 million, but the company continues to incur losses and is evaluating additional financing.
• SINTX has begun full commercialization of its FDA-cleared SiNAPTIC foot-and-ankle system and reported initial commercial revenue in 2026. It is also advancing silicon-nitride/PEEK 3D-printed implants and textile applications, though further studies and regulatory steps remain before broader commercialization.
• The company could not provide an expectation for delivery of the remaining portion of $3.2 million in purchase orders during the fourth quarter. Management cautioned that quarterly revenue may fluctuate with order timing, production schedules, and shipments.

Sintx Technologies Stock Performance

Shares of SINT stock traded down $0.04 during midday trading on Thursday, hitting $1.62. 64,555 shares of the company were exchanged, compared to its average volume of 33,820. The firm has a market capitalization of $7.00 million and a P/E ratio of -0.33. The firm’s 50 day moving average price is $1.80 and its two-hundred day moving average price is $2.20. Sintx Technologies has a 52 week low of $1.40 and a 52 week high of $4.46.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SINT. Ascendiant Capital Markets upped their target price on shares of Sintx Technologies from $12.00 to $12.50 and gave the company a “buy” rating in a report on Thursday, October 1st. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, October 15th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $9.50.

About Sintx Technologies

SINTX Technologies, Inc (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications.

In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.